• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[显微镜下尿液分析筛查恶性细胞的临床病理研究]

[Clinicopathological study on microscopic urinalysis as screening for malignant cells].

作者信息

Kawabe T, Kaneoka A, Koichi K, Murakami N, Kuroki T, Kinugasa M, Miyake S, Takasu K

出版信息

Rinsho Byori. 1989 Oct;37(10):1167-72.

PMID:2601075
Abstract

Study on detection of malignant cells in urinary sediments using supravital staining was described. We examined 96,554 specimens of urinary sediments for 2 years from January 1985 to December 1986. The results of microscopic urinalysis were compared with the cytological and histological diagnoses. Atypical cells were found in 138 patients, and 47 (34.1%) cancers were diagnosed histologically among them. These included 33 bladder cancer, 1 ureter cancer, 1 renal pelvic cancer, 2 prostate cancers, 1 rectal cancer, and 9 uterine cancers. Seven patients of them had not been under suspicion of malignancy yet before atypical cells were detected. Therefore microscopic urinalysis caused the triggers of cancer diagnoses. For bladder cancers, the positive rates in microscopic urinalysis were 43.4%, and those in urinary cytology were 52.4%. The positivity revealed higher in high-grade cancers than in low-grade. As compared with the results between microscopic urinalysis and urinary cytology in identical patients, the rate of correspondence between them was 89.5%. In 61.2% of positive and suspicious urinary cytology, atypical cells were not found. Atypical cells were seen in negative urinary cytology of 26 cases, and 5 cases of cancers were diagnosed histologically. These suggested that microscopic urinalysis as a screening for malignant cells was useful to detect urinary tract malignancy combining with urinary cytology.

摘要

描述了一项关于使用活染法检测尿沉渣中恶性细胞的研究。1985年1月至1986年12月的两年间,我们检查了96554份尿沉渣标本。将显微镜下尿液分析结果与细胞学和组织学诊断结果进行了比较。在138例患者中发现了非典型细胞,其中47例(34.1%)经组织学诊断为癌症。这些包括33例膀胱癌、1例输尿管癌、1例肾盂癌、2例前列腺癌、1例直肠癌和9例子宫癌。其中7例在检测到非典型细胞之前尚未被怀疑患有恶性肿瘤。因此,显微镜下尿液分析引发了癌症诊断。对于膀胱癌,显微镜下尿液分析的阳性率为43.4%,尿液细胞学的阳性率为52.4%。高级别癌症的阳性率高于低级别癌症。与同一患者的显微镜下尿液分析和尿液细胞学结果相比,两者之间的符合率为89.5%。在61.2%的阳性和可疑尿液细胞学检查中,未发现非典型细胞。在26例尿液细胞学阴性的病例中发现了非典型细胞,其中5例经组织学诊断为癌症。这些表明,显微镜下尿液分析作为恶性细胞的筛查方法,结合尿液细胞学检查,对检测尿路恶性肿瘤是有用的。

相似文献

1
[Clinicopathological study on microscopic urinalysis as screening for malignant cells].[显微镜下尿液分析筛查恶性细胞的临床病理研究]
Rinsho Byori. 1989 Oct;37(10):1167-72.
2
Cytologic diagnosis of low-grade papillary urothelial neoplasms (low malignant potential and low-grade carcinoma) in the context of the 1998 WHO/ISUP classification.1998年世界卫生组织/国际泌尿病理学会分类背景下低级别乳头状尿路上皮肿瘤(低度恶性潜能和低级别癌)的细胞学诊断
Diagn Cytopathol. 2003 Apr;28(4):186-90. doi: 10.1002/dc.10263.
3
Multitarget fluorescence in situ hybridization assay detects transitional cell carcinoma in the majority of patients with bladder cancer and atypical or negative urine cytology.多靶点荧光原位杂交检测法可在大多数膀胱癌且尿液细胞学检查不典型或呈阴性的患者中检测出移行细胞癌。
J Urol. 2003 Jun;169(6):2101-5. doi: 10.1097/01.ju.0000066842.45464.cc.
4
Analysis of urine cytology at a community hospital.
J Ayub Med Coll Abbottabad. 2003 Apr-Jun;15(2):20-3.
5
Could nuclear matrix protein 22 (NMP22) play a role with urine cytology in screening for bladder cancer?--experience at Kuwait University.核基质蛋白22(NMP22)在膀胱癌筛查中能否与尿细胞学检查发挥协同作用?——科威特大学的经验
Cytopathology. 2008 Dec;19(6):369-74. doi: 10.1111/j.1365-2303.2008.00586.x. Epub 2008 Jul 9.
6
Early diagnosis and monitoring of superficial transitional cell carcinoma by microsatellite analysis on urine sediment.通过对尿沉渣进行微卫星分析对浅表性移行细胞癌进行早期诊断和监测。
Oncol Rep. 2005 Mar;13(3):531-7.
7
Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumors.核基质蛋白、纤连蛋白、膀胱癌抗原及晨尿细胞学检查在膀胱肿瘤检测中的比较评估
J Urol. 2002 Aug;168(2):465-9.
8
[Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma].[尿BTA-TRAK在浅表性移行细胞膀胱癌随访中的应用]
Arch Esp Urol. 2002 Jan-Feb;55(1):41-9.
9
The value of upper tract cytology after transurethral resection of bladder tumor in patients with bladder transitional cell cancer.膀胱移行细胞癌患者经尿道膀胱肿瘤切除术后上尿路细胞学检查的价值。
J Urol. 1999 Jan;161(1):77-9; discussion 79-80.
10
[Evaluation of urinary cytology for upper urinary tract disease].[上尿路疾病的尿细胞学评估]
Hinyokika Kiyo. 1986 Feb;32(2):177-82.